Medication info
Miarilem Tablets 2/500 mg

Miarilem Tablets 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White elongated film-coated tablet
Packaging
30 tablets per bottle, 300 tablets per bottle
Approval status
Active

MFDS item code 201107201 · Approved 2011.09.27 · Insurance code 650302810

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary management and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. The combination administration of Glimepiride and Metformin allows for more effective management of blood sugar levels. This contributes to stabilizing blood sugar levels in patients and assists in diabetes treatment.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This drug may cause severe lactic acidosis or hypoglycemia, so special care should be taken in situations where kidney function rapidly deteriorates. If symptoms of dehydration occur, it is advisable to temporarily discontinue this drug and consult a physician. When used with medications that can cause acute renal impairment, renal function should be closely monitored. In patients with cardiovascular diseases, the use of this drug may increase the risk of cardiovascular mortality, so caution is required. This drug is not to be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver or kidney dysfunction, pregnant or breastfeeding women. Additionally, administration of this drug should be temporarily suspended before and after tests using radiographic contrast agents, and it should be resumed only after renal function has stabilized. Patients at high risk for hypoglycemia, malnutrition, and those with high alcohol intake require dosage adjustments and careful monitoring. Gastrointestinal side effects (such as diarrhea, nausea, vomiting, etc.) may occur initially but are mostly temporary and can be alleviated by taking the medication with food. Rarely, vitamin B12 deficiency may occur, so regular blood testing is recommended during long-term use. This drug may interact with other medications, so it is essential to inform a physician or pharmacist of any other medications being taken. Caution is needed when driving or operating machinery due to the potential for hypoglycemia or dexterity impairment. In case of overdose, symptoms of hypoglycemia may occur, and immediate medical attention should be sought. This drug requires careful observation and dosage adjustments when used in children or the elderly. It is important to regularly monitor blood sugar levels and renal function to confirm the efficacy and safety of treatment.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, anorexia, indigestion, constipation, abdominal pain, discomfort, metallic taste, visual impairment, taste disturbance, erythema, pruritus, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, peripheral neuropathy, increased liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity dermatitis, decreased serum sodium concentration, decreased thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, headache, extreme hunger, fatigue, sleep disorder, instability, aggression, attention deficit, inability to concentrate, abnormal reaction, depression, confusion, speech disorder, aphasia, tremor, paralysis, sensory disturbance, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak breathing, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations, angina, deep vein thrombosis, vertigo, liver dysfunction, benign prostatic hyperplasia, palpitations, dizziness, leg edema, cardiac arrest, rectal carcinoma, arthralgia, facial edema, erectile dysfunction, facial flushing, gastritis, hypoglycemic coma, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent air entry, at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the drug's efficacy for an extended period.

Appearance and packaging

Appearance

White elongated film-coated tablet

Package unit

30 tablets per bottle, 300 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.